Navigation Links
Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device

Health professionals have been recently notified that some older pacemakers manufactured by Guidant Corporation may malfunction due to a build-up of moisture //in the device. The products include early generation designs that have not been sold or implanted in the past 4 years, some of the names of the affected models include the Pulsar Max, Pulsar, Discovery, Meridian, Pulsar Max II, Discovery II, Virtus Plus II, Intelis II, and Contak TR.

The defect involves a hermetic sealing component that is found to gradually degrade, resulting in a higher than normal moisture content within the pacemaker late in its life.

The manufacturers say that no failures have been reported in the first 44 months of pacemaker use but the likelihood of occurrence increases with implant time. According to the report there are approximately 28,000 devices that have been implanted worldwide.

Till date there have been 20 confirmed reports of loss of pacing output, including five patients experiencing syncope indicates the report.

The manufactures, Guidant recommends that physicians should consider the unique needs of every patient, but should consider replacing devices for pacemaker-dependent patients, as well as selecting a suitable MSR setting and consider programming the accelerometer to OFF in case of inappropriate sustained pacing at MSR. The manufacturers are also offering a supplemental warranty program to December 31, 2005, with the option of a free replacement device for certain patients.

Links : http://www.medindia.net/glossary
/glossary.asp


http://www.medindia.net/insurance
/insurance_faq.htm

'"/>




Page: 1

Related medicine news :

1. Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers
2. Hospital Services Still Paralysed Inspite Of The Withdrawal Of The Strike
3. Risk Of Death Increases With Sudden Withdrawal Of Medications
4. Sudden Opioid Withdrawal Results in ‘Broken Heart Syndrome
5. Cadbury Dismisses Rumors of Withdrawal of More Products
6. Andhra Wants Withdrawal of Warning Signal from ‘Beedi’ Packes
7. HIV Testing Improves After Withdrawal of Consent Letter
8. FDA Announces Voluntary Withdrawal of Pergolide Products
9. High Court Issues Notice To Centre On Smoking Ban In Films
10. Notice issued against health minister and four others
11. Brinda Karat Receives Legal Notice over Ramdev Issue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/25/2017)... ... 25, 2017 , ... FCPX users now have the ability to sharpen a ... ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, ... spectrum tools users can visually see the color range effected with ease all within ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Only two ... International Luxury Travel Market (ILTM) show in Cannes (France), XO Private has initiated a ... tome, the 420-page book measures almost a metre across when open, weighs in at ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... provost of Liberty University, has officially announced the appointment of Peter A. Bell, ... College of Osteopathic Medicine (LUCOM), beginning April 10. Dr. Bell comes to ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ... is so critically important that we all are aware of our options and ... is proud to announce the launch of its newest edition of "Vision and ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 24, 2017 ... Monteverde & Associates PC , a boutique securities firm ... New York City , announces that a class ... Massachusetts  against Inotek Pharmaceuticals Corporation ... of the Company,s securities between July 23, 2015 and December ...
(Date:2/24/2017)...  Directors from Pharma To Market Pty Ltd and Ador Consulting ... in the founding of Pharma To Market Pte Ltd, based in ... pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia , ... Singapore based entity. Joelle brings with her an extensive ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
Breaking Medicine Technology: